Reportedly, the Medtronic Infuse bone graft can lead to serious complications when it is used in unapproved procedures. The protein has only been FDA-approved for use in lower spine repair surgery to promote bone growth, and when used in cervical spine (upper spine and neck) surgery, may put the patient at risk for Infuse bone graft complications. Infection, cyst formation, male infertility and death are among the serious Medtronic infuse problems reportedly associated with the product.
Reportedly, studies funded by the manufacturer neglected to disclose serious Medtronic Infuse problems. No infuse bone graft complications were reported in 13 clinical trials funded by the company, while data provided to U.S. regulations and other publications found that up to 50% of patients suffered from Medtronic infuse problems, according to the Spine Journal. Patients are particularly at risk for Infuse bone graft complications when undergoing cervical spine fusions, a procedure for which the product was not FDA-approved.
The following are among the reported Medtronic Infuse problems:
The FDA has also received reports of additional Infuse bone graft complications including swelling of the throat and neck tissue, which can lead to difficulty swallowing, breathing or speaking.
Before commenting, please review our comment policy.